News | March 09, 2022
Indian Pharma Market growth flat in Feb 2022
Price was the key driver for the period
Price was the key driver for the period
Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time
Subscribe To Our Newsletter & Stay Updated
